Asieris Pharmaceuticals

Asieris Pharmaceuticals

Pharmaceuticals, 201 King of Prussia Rd, Radnor, Pennsylvania, 19087, United States, 201-500 Employees

asieris.com

  • LinkedIn

Who is ASIERIS PHARMACEUTICALS

Asieris Pharmaceuticals, founded in March 2010, is a global innovative pharma company specializing in new drugs for the treatment of genitourinary tumors and other major diseases. We stri...

Read More

map
  • 201 King of Prussia Rd, Radnor, Pennsylvania, 19087, United States Headquarters: 201 King of Prussia Rd, Radnor, Pennsylvania, 19087, United States
  • 2010 Date Founded: 2010
  • 201-500 Employees: 201-500
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

checked-icon Does something look wrong? Fix it. | View contact records from ASIERIS PHARMACEUTICALS

Asieris Pharmaceuticals Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Asieris Pharmaceuticals

Answer: Asieris Pharmaceuticals's headquarters are located at 201 King of Prussia Rd, Radnor, Pennsylvania, 19087, United States

Answer: Asieris Pharmaceuticals's official website is https://asieris.com

Answer: Asieris Pharmaceuticals's revenue is $1 Million to $5 Million

Answer: Asieris Pharmaceuticals has 201-500 employees

Answer: Asieris Pharmaceuticals is in Pharmaceuticals

Answer: Asieris Pharmaceuticals contact info: Phone number: Website: https://asieris.com

Answer: Asieris Pharmaceuticals, founded in March 2010, is a global innovative pharma company specializing in new drugs for the treatment of genitourinary tumors and other major diseases. We strive to improve human health and help people live a more dignified life. We aim to become a global pharma leader that integrates R&D, manufacturing and commercialization in our areas of focus, as we provide best-in-class integrated diagnosis and treatment solutions for patients in China and worldwide. The company has been developing its proprietary R&D platform and core technologies, exploring new mechanisms of action, and efficiently screening and evaluating drug candidates. With a well-established in-house R&D system and expertise in global drug development, Asieris is committed to launching first-in-class drugs and other innovative products to address huge unmet needs in its areas of focus. Asieris is also enhancing its pipeline for genitourinary diseases via proprietary R&D and strategic partnerships, while closely following cutting-edge technologies and therapeutics. The company strives to discover and identify unmet clinical needs, and adopts a forward-looking approach in product planning and life-cycle management. We aim to establish an outstanding portfolio that covers diagnosis and treatment in a bid to benefit more patients in China and globally.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access